Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CORT
EXEL
Add up to 3 more stocks
CORT
Corcept Therapeutics Incorporated
-3.27%
$118.04-3.99Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$12.76B
52W Range
$28.66 - $126.38
EXEL
Exelixis, Inc.
-0.26%
$58.70-0.16Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$14.75B
52W Range
$33.76 - $61.14
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 281.04 | 18.40 |
| Forward P/E | N/A | 16.71 |
| PEG Ratio | N/A | 0.36 |
| P/B Ratio | 18.08 | 8.00 |
| P/S Ratio | 15.36 | 6.06 |
| P/FCF Ratio | 119.34 | 12.74 |
| EV/EBITDA | 1434.32 | 14.64 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 98.3% | 96.5% |
| Operating Margin | 0.8% | 39.9% |
| Net Margin | 6.6% | 35.3% |
| ROE | 7.8% | 46.7% |
| ROA | 6.2% | 34.5% |
| ROIC | 0.9% | 37.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.86 | 3.46 |
| Quick Ratio | 2.77 | 3.38 |
| Debt/Equity | 0.01 | 0.09 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.